Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death. Researchers have uncovered a protein profile that may accurately predict whether a cancer will be tamoxifen resistant.


   

Today in Popular Press...keeping you current

Be Overweight And Live Longer, German Study Suggests
ScienceDaily, 10/19/09

Even Low Alcohol Consumption Has A Negative Impact On Overall Health, Researchers Argue
ScienceDaily, 10/26/09

Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
EurekAlert, 11/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address